- Home
- CHRS vs EPM Comparison
CHRS vs EPM Comparison
Compare CHRS & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- EPM
- Stock Information
- Founded
- CHRS 2010
- EPM 2003
- Country
- CHRS United States
- EPM United States
- Employees
- CHRS N/A
- EPM N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- EPM Oil & Gas Production
- Sector
- CHRS Health Care
- EPM Energy
- Exchange
- CHRS Nasdaq
- EPM Nasdaq
- Market Cap
- CHRS 185.5M
- EPM 188.8M
- IPO Year
- CHRS 2014
- EPM 1996
- Fundamental
- Price
- CHRS $1.52
- EPM $4.94
- Analyst Decision
- CHRS Strong Buy
- EPM Strong Buy
- Analyst Count
- CHRS 4
- EPM 1
- Target Price
- CHRS $5.38
- EPM $8.25
- AVG Volume (30 Days)
- CHRS 10.1M
- EPM 212.5K
- Earning Date
- CHRS 11-06-2024
- EPM 02-04-2025
- Dividend Yield
- CHRS N/A
- EPM 9.84%
- EPS Growth
- CHRS N/A
- EPM N/A
- EPS
- CHRS N/A
- EPM 0.14
- Revenue
- CHRS $304,340,000.00
- EPM $87,172,000.00
- Revenue This Year
- CHRS $1.64
- EPM $13.15
- Revenue Next Year
- CHRS $16.98
- EPM N/A
- P/E Ratio
- CHRS N/A
- EPM $34.89
- Revenue Growth
- CHRS 44.19
- EPM N/A
- 52 Week Low
- CHRS $0.66
- EPM $4.59
- 52 Week High
- CHRS $3.70
- EPM $6.29
- Technical
- Relative Strength Index (RSI)
- CHRS 52.47
- EPM 26.48
- Support Level
- CHRS $1.45
- EPM $4.87
- Resistance Level
- CHRS $1.85
- EPM $5.29
- Average True Range (ATR)
- CHRS 0.23
- EPM 0.17
- MACD
- CHRS -0.03
- EPM -0.10
- Stochastic Oscillator
- CHRS 3.88
- EPM 5.94
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-approved oncology products, including LOQTORZI. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company generates revenue from the United States.
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent oil and gas company operating in the United States. It is engaged predominantly in the acquisition, exploitation, and development of properties for the production of crude oil and natural gas, onshore in the United States. The company's revenues are generated from its crude oil, natural gas, and NGL production from the Jonah Field in Sublette County, Wyoming; the Williston Basin in North Dakota; the Barnett Shale located in North Texas; the Hamilton Dome Field in Wyoming; and the Delhi Field in Northeast Louisiana.